AMGN Amgen
- Official Name: AMGEN INC.
- Headquarters: One Amgen Center Drive, THOUSAND OAKS, CA, 91320-1799 US
- CEO: Robert A. Bradway
- Website: amgen.com
- Key Investor: VANGUARD GROUP INC | 9.83%
- Dedicated Investor: ROUND HILL ASSET MANAGEMENT | 9.69%
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-17 | 1 | Lost by 2.145 | (1.528) - 0.617 | ||
| 2025-07-24 | 2 | Lost by 3.682 | 2.899 - 6.581 | ||
| 2025-07-29 | 2R | Won by 3.450 | 2.349 - (1.101) | ||
| 2025-07-31 | 3 | Lost by 12.306 | (7.955) - 4.351 | ||
| 2025-08-07 | 4 | Lost by 3.570 | (3.118) - 0.452 | ||
| 2025-08-07 | 1R | Lost by 1.554 | 0.504 - 2.058 | ||
| 2025-08-12 | 3R | Lost by 0.964 | (0.158) - 0.806 | ||
| 2025-08-14 | 5 | Won by 0.385 | 1.814 - 1.429 | ||
| 2025-08-21 | 6 | Won by 3.889 | 1.996 - (1.893) | ||
| 2025-08-28 | 7 | Lost by 1.822 | (3.537) - (1.715) | ||
| 2025-09-03 | 1R | Lost by 1.312 | (1.069) - 0.243 | ||
| 2025-09-04 | 8 | Lost by 6.693 | (1.876) - 4.817 | ||
| 2025-09-11 | 9 | Won by 2.498 | 0.937 - (1.561) | ||
| 2025-09-18 | 10 | Lost by 3.539 | (2.540) - 0.999 | ||
| 2025-09-25 | 11 | Won by 0.709 | (1.338) - (2.047) | ||
| 2025-10-02 | 12 | Won by 10.367 TOTW | 8.608 - (1.759) | ||
| 2025-10-09 | 13 | -- - -- | |||
| 2025-10-16 | 14 | -- - -- | |||
| 2025-10-23 | 15 | -- - -- |
Latest News
Yahoo - 2025-10-08
2 S&P 500 Stocks to Target This Week and 1 Facing Challenges
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. B...
Yahoo - 2025-10-08
Does Amgen’s Recent 4.7% Surge Signal Room for Growth in 2025?
If you are scratching your head about whether to buy, sell, or just hold on to Amgen stock, you are not alone. The biotech giant has had an interestin...
Yahoo - 2025-10-07
Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60%
AMGN rolls out AmgenNow, a direct-to-consumer program debuting with Repatha at a 60% lower price to boost patient access and affordability.
Yahoo - 2025-10-06
Amgen (AMGN) Stock Sinks As Market Gains: Here's Why
Amgen (AMGN) reached $294.12 at the closing of the latest trading day, reflecting a -1.27% change compared to its last close.
Yahoo - 2025-10-06
Amgen Slashes Drug Price After Trump Threat--Repatha Now 60% Cheaper Online
Biotech giant rushes to comply with Trump's drug price crackdown, joins Pfizer in avoiding tariff backlash
Yahoo - 2025-10-06
Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts
The biotechnology company said that it has launched AmgenNow, a new direct-to-patient program, starting with its drug Repatha.
Yahoo - 2025-10-06
Bullous Pemphigoid Market Analysis and Forecast Report 2025-2035
Emerging technologies in diagnostics and telemedicine are transforming patient management, although high costs and variable patient responses remain b...
Yahoo - 2025-10-06
Here's Why Amgen (AMGN) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zack...
SeekingAlpha - 2025-10-06
My Top 5 Biotech Stocks Big Pharma Could Buy Next
Many of the biotech stocks remain outside of Mr. Market's interest zone. Check out five biotech firms that may be of interest to Big Pharma playe...
Yahoo - 2025-10-06
GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings
SANTA MONICA, Calif., October 06, 2025--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the availabili...
Yahoo - 2025-10-06
Is There An Opportunity With Amgen Inc.'s (NASDAQ:AMGN) 49% Undervaluation?
Key Insights The projected fair value for Amgen is US$586 based on 2 Stage Free Cash Flow to Equity Current share price...
Yahoo - 2025-10-06
AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.
Amgen (NASDAQ: AMGN) today announced the launch of AmgenNow, a new direct-to-patient program starting with Repatha® (evolucumab). This follows landma...
SeekingAlpha - 2025-10-04
October Dogs Of The Dow Flash One Ideal 'Safer' Dividend Buy
Discover top Dow Dogs for dividend income. See why Verizon leads as a safe high-yield pick and find key strategies for safer Dow dividend investingâ...
Yahoo - 2025-10-04
4 Reasons to Buy Amgen Stock Right Now
For those with a sufficiently long investment horizon, the stock looks attractive.
Show more
Yahoo - 2025-10-03
Amgen’s Phase III data supports FDA label expansion of Repatha
Yahoo - 2025-10-03
September in Review: 11 Top Health Press Releases
Yahoo - 2025-10-02
Amgen (AMGN): Examining Valuation After Recent 6% Share Price Rise
Yahoo - 2025-10-02
Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term
Yahoo - 2025-10-02
LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS
Yahoo - 2025-10-02
Amgen claims ‘landmark’ study result that could widen heart drug’s use
Yahoo - 2025-10-02
2 High-Yield Dividend Growth Stocks to Buy in October and Hold for a Decade or Longer
Yahoo - 2025-10-02
Amgen (AMGN) Announces $650M Puerto Rico Facility Expansion
Yahoo - 2025-10-01
Marjorie Taylor Greene Loads Up On Six-Figure Treasury Bill— Diversifies Portfolio With Bitcoin ETF, Tech Stocks
Yahoo - 2025-10-01
S&P 500, Dow Reach New Peaks as Traders Look Past Ongoing Shutdown
Yahoo - 2025-10-01
Drug Stock Rally Helps Push Dow and S&P 500 to Records
Yahoo - 2025-10-01
US Equity Indexes Rise as Healthcare Jumps, October Rate-Cut Certainty Increases Amid Surprise Fall in Private Payrolls
Yahoo - 2025-10-01
Why Are Amgen (AMGN) Shares Soaring Today
Yahoo - 2025-10-01
Healthcare Helps Lift US Equity Indexes After Federal Shutdown Begins
Yahoo - 2025-10-01
Equities Rise Intraday as Markets Look Past Shutdown
Yahoo - 2025-10-01
US Equity Indexes Mixed Amid Healthcare Gains While Treasury Yields Drop as Partial Shutdown Begins
Yahoo - 2025-10-01
Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff
Yahoo - 2025-10-01
Immatics Appoints Venkat Ramanan as Chief Financial Officer
Yahoo - 2025-09-30
Drug Manufacturers Help Push US Equity Indexes Higher While Government Shutdown Looms
Yahoo - 2025-09-30
Pfizer Stock Soars on Trump’s New Drug Pricing Plan. Here’s Why.
Yahoo - 2025-09-30
Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know
Yahoo - 2025-09-30
Bank of America Securities Maintains a Sell Rating on Amgen (AMGN)
SeekingAlpha - 2025-09-30
Regeneron: Growth Catalysts Incoming
Yahoo - 2025-09-30
Amgen to expand US drug production with $650M investment
SeekingAlpha - 2025-09-29
Cheapest S&P 500 Stocks Ranked: 30 Best Value Buys
Yahoo - 2025-09-29
Amgen to invest $650m in US manufacturing network expansion
Yahoo - 2025-09-29
Amgen Inc.’s (AMGN) and AstraZeneca’s (AZN) Tezspire Receives Positive Recommendation from the EU Medicines Agency
Yahoo - 2025-09-28
Amgen Inc. (AMGN) Invests $650M to Expand Puerto Rico Biologics Facility, Adds 750 Jobs
Yahoo - 2025-09-27
Expansion of U.S. Manufacturing and Tezspire Approval Might Change the Case for Investing in Amgen (AMGN)
SeekingAlpha - 2025-09-27
Regeneron: Strong R&D Pipeline Drives Growth Outlook
SeekingAlpha - 2025-09-27
AbbVie For Healthy Dividend Growth
Yahoo - 2025-09-26
GLP-1 race evolves as Amgen & weight-loss pills enter the scene
Yahoo - 2025-09-26
All bark, no bite: Trump’s latest trade war turns into another TACO salad for Wall Street
Yahoo - 2025-09-26
These Stocks Moved the Most Today: Eli Lilly, Electronic Arts, Intel, GlobalFoundries, Boeing, AppLovin, Costco, and More
Yahoo - 2025-09-26
Sector Update: Health Care Stocks Gain Late Afternoon
Yahoo - 2025-09-26
Sector Update: Health Care Stocks Rise Friday Afternoon
Yahoo - 2025-09-26
US Equity Indexes Rise as Investors Assess Latest Inflation Data
MarketWatch - 2025-09-26
Eli Lilly, Pfizer, Amgen Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.
Yahoo - 2025-09-26
US Equity Indexes Rise in Midday Trading
Yahoo - 2025-09-26
Top Midday Stories: Amgen to Invest $650 Million to Expand US Manufacturing; Trump Signs TikTok Deal Order
Yahoo - 2025-09-26
Analysts Cite Amgen’s (AMGN) Strong Therapies Pipeline to Reaffirm Bullish Outlook
Yahoo - 2025-09-26
US, European pharma stocks steady after Trump's tariff move, Asia slips
Yahoo - 2025-09-26
Honeywell International Inc. (HON) Raises $600M for Quantum Arm Quantinuum at $10B Valuation
Yahoo - 2025-09-26
These Stocks Are Moving the Most Today: Eli Lilly, Intel, Paccar, GlobalFoundries, Boeing, Concentrix, Costco, and More
Yahoo - 2025-09-26
CASI Pharmaceuticals Appoints James Huang to Board of Directors
Yahoo - 2025-09-26
AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS
SeekingAlpha - 2025-09-26
President Trump's 100% Tariff Threat: What It Means For Your Pharma Portfolio
SeekingAlpha - 2025-09-26
Viridian Therapeutics: De-Risked Leadership In Thyroid Eye Disease
MarketWatch - 2025-09-26
Amgen to Invest $650M in U.S. Production Expansion as Trump Hikes Tariffs
Yahoo - 2025-09-25
Is Amgen (AMGN) a Safe Bet for Income Investors in Cheap Quarterly Dividend Stocks?
MarketWatch - 2025-09-25
Dow falls 175 points on losses for Amgen, Nike shares
MarketWatch - 2025-09-25
Dow down 311 points on losses for shares of Nike, Amgen
Yahoo - 2025-09-25
Dr. Robert Lenz Joins Unlearn as Strategic Advisor
SeekingAlpha - 2025-09-25
Amgen: MariTide's Progress, Reassessment Of The Horizon Acquisition
Yahoo - 2025-09-24
Amgen (AMGN) Dips More Than Broader Market: What You Should Know
SeekingAlpha - 2025-09-24
Takeda: Excellent Pipeline Kaizen - 6 Drugs, $20 Billion Annually
MarketWatch - 2025-09-24
Dow's 119-point drop led by losses in Amgen, Apple shares
SeekingAlpha - 2025-09-24
Amgen: Imdelltra Could Be The Next Game Changer
Yahoo - 2025-09-24
Pharma’s next generation of blockbuster antibodies takes a ‘more is better’ approach
Yahoo - 2025-09-24
A Once-in-a-Decade Opportunity: 10 Billion Reasons to Pay Attention to This Monster Quantum Computing Company (Hint: Not IonQ)
Yahoo - 2025-09-23
Amgen (NASDAQ:AMGN) jumps 4.2% this week, though earnings growth is still tracking behind three-year shareholder returns
Yahoo - 2025-09-22
Amgen (AMGN) Moves 3.5% Higher: Will This Strength Last?
Yahoo - 2025-09-22
Cellares Appoints Former Kite Global Ops Leader, Christopher McDonald, to Board of Advisors
SeekingAlpha - 2025-09-22
Pfizer Buys Obesity Drug Developer Metsera: Buy Today And Benefit From CVRs
Yahoo - 2025-09-19
Why Amgen (AMGN) Stock Is Trading Up Today
Yahoo - 2025-09-19
Sector Update: Health Care Stocks Mixed Late Afternoon
Yahoo - 2025-09-19
EMA Backs Amgen Drug For Rare Autoimmune Disorder
MarketWatch - 2025-09-19
Dow's 236-point rally led by gains in Amgen, Apple stocks
Yahoo - 2025-09-19
Amgen's Uplizna Receives European Human Medicines Committee Recommendation for IgG4-Related Disease
MarketWatch - 2025-09-19
Apple, Amgen share gains contribute to Dow's 118-point jump
Yahoo - 2025-09-18
J&J Expects Innovative Medicines Growth Despite Stelara LOE: Here's Why
Yahoo - 2025-09-17
Why Amgen (AMGN) is a Top Value Stock for the Long-Term
Yahoo - 2025-09-17
Ollin debuts with $100M and plans to challenge top-selling eye drugs
Yahoo - 2025-09-16
What Do Analysts Think About Amgen Inc. (AMGN)?
Yahoo - 2025-09-16
AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play?
Yahoo - 2025-09-16
Amgen Insiders Sold US$12m Of Shares Suggesting Hesitancy
Yahoo - 2025-09-16
Drug developer Dualitas launches $65 million funding round
Yahoo - 2025-09-16
Immuneering Appoints Dr. Thomas Schall as Chairman of the Board
Yahoo - 2025-09-15
Stock Market Today: Indexes Up As Chips Fall On China; Buffett Stock Tests Entry (Live Coverage)
SeekingAlpha - 2025-09-15
How Trump's Drug Pricing Policies Could Trigger An Epic Pharma Collapse
Yahoo - 2025-09-15
Why California’s biopharma boom is critical for logistics
Yahoo - 2025-09-15
Samsung Biologics, Amgen and Biocon invest in US pharma sites
Yahoo - 2025-09-14
2 Healthcare Dividend Stocks to Buy and Hold
SeekingAlpha - 2025-09-14
Amgen: Buy The Dip Opportunity
Yahoo - 2025-09-14
Guggenheim Maintains a Hold on Amgen Inc. (AMGN)
SeekingAlpha - 2025-09-13
The GLP-1 Oral Frontier: Novo Nordisk And Eli Lilly's 100-Year Duel Enters Its Next Chapter
MarketWatch - 2025-09-12
Merck, Sherwin-Williams Co. share losses lead Dow's 287-point drop
SeekingAlpha - 2025-09-12
What Looms Ahead After The Dow Jones Topped A Record Of 46,000
MarketWatch - 2025-09-11
Amgen Inc. stock underperforms Thursday when compared to competitors despite daily gains
Yahoo - 2025-09-10
Amgen (AMGN) And Kyowa Kirin Reveal Initial Results From Rocatinlimab ASCEND Study
Yahoo - 2025-09-10
Kriya, Odyssey secure ‘megarounds’; Amgen boosts R&D leadership
Yahoo - 2025-09-10
The Bull Case For Amgen (AMGN) Could Change Following Phase 3 Rocatinlimab Data Release
Yahoo - 2025-09-09
Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis
SeekingAlpha - 2025-09-09
Metsera: An Emerging Contender In The GLP‑1 Arena
SeekingAlpha - 2025-09-09
Amgen Inc. (AMGN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
Yahoo - 2025-09-09
Amgen and Kyowa Kirin Announce Top-Line Results From Rocatinlimab Phase 3 ASCEND Long-Term Extension Study in Adults With Moderate to Severe Atopic Dermatitis
Yahoo - 2025-09-08
If You'd Invested $10,000 in Amgen Stock (AMGN) 3 Years Ago, Here's How Much You'd Have Today
SeekingAlpha - 2025-09-08
Bristol-Myers Squibb: Why Q2 Results Signal A Turning Point
MarketWatch - 2025-09-08
Verizon, Merck share losses contribute to Dow's 118-point drop
Yahoo - 2025-09-07
William Blair Reiterates a Buy on Amgen Inc (AMGN)
SeekingAlpha - 2025-09-07
The BLSH Strategy: The Compounding Machine
SeekingAlpha - 2025-09-05
September Dogs Of The Dow Unleash One Ideal 'Safer' DiviDog
SeekingAlpha - 2025-09-05
Dividend Champion, Contender, And Challenger Highlights: Week Of September 7
MarketWatch - 2025-09-05
Amgen Inc. stock outperforms competitors on strong trading day
SeekingAlpha - 2025-09-05
Pfizer: Still A Bargain Despite Kennedy's Anti-Vaccine Attacks
Yahoo - 2025-09-04
How Much Would It Take To Earn $100 A Month From Amgen Stock
Yahoo - 2025-09-04
Nvidia Invests in Honeywell’s Quantinuum. What It Means for D-Wave, IonQ, and Quantum Stocks.
Yahoo - 2025-09-04
Why Is Sanofi Stock Falling Thursday?
Yahoo - 2025-09-04
Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory
Yahoo - 2025-09-03
Amgen (AMGN) Unveils US$600 Million Innovation Hub Expanding R&D Efforts in California
SeekingAlpha - 2025-09-03
Amgen Inc. (AMGN) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
Yahoo - 2025-09-02
Sector Update: Health Care Stocks Retreat Late Afternoon
Yahoo - 2025-09-02
Leerink Partners Maintains a Hold on Amgen (AMGN)
Yahoo - 2025-09-02
Nio, Signet Jewelers, Amgen: Trending Tickers
Yahoo - 2025-09-02
AMGEN INVESTING MORE THAN HALF A BILLION DOLLARS IN NEW, STATE-OF-THE-ART CENTER FOR SCIENCE AND INNOVATION AT U.S. GLOBAL HEADQUARTERS
Yahoo - 2025-09-02
Amgen to invest $600M in new US center; Sanofi drug for ITP approved
MarketWatch - 2025-09-02
Amgen to Invest $600 Million at California Headquarters
Yahoo - 2025-09-02
Amgen Inc. (AMGN)’s Experimental Obesity Drug MariTide Shows Up to 20% Weight Loss Potential
Yahoo - 2025-09-01
Here’s What Jim Cramer Wishes Amgen Inc. (AMGN) Should Do To Its Drug That Hurts Like A “Banshee”
Yahoo - 2025-09-01
Is Amgen Stock Underperforming the S&P 500?
SeekingAlpha - 2025-09-01
BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH
Yahoo - 2025-09-01
2 Profitable Stocks Worth Your Attention and 1 We Avoid
Yahoo - 2025-08-31
Piper Sandler Lifts PT on Amgen (AMGN) to $342 From $328, Keeps an Overweight Rating
Yahoo - 2025-08-30
With 81% ownership of the shares, Amgen Inc. (NASDAQ:AMGN) is heavily dominated by institutional owners
Yahoo - 2025-08-30
Does Imdelltra Royalty Deal Reinforce Royalty Pharma’s Long-Term Asset Strategy (RPRX)?
Yahoo - 2025-08-29
AMGEN TO PRESENT AT THE 2025 WELLS FARGO HEALTHCARE CONFERENCE
Yahoo - 2025-08-29
Amgen partners with Veeva Systems to enhance clinical trial processes
Yahoo - 2025-08-28
Veeva Announces Collaboration with Global Biotech to Further Accelerate Clinical Trial Innovation
Yahoo - 2025-08-28
2 Dividend Stocks to Hold for the Next 10 Years
Yahoo - 2025-08-26
Amgen (AMGN) Gains FDA Approval For Broadened Repatha® Use In Cardiovascular Risk Management
Yahoo - 2025-08-26
AMGN Up Almost 14% YTD: Should You Buy, Sell or Hold the Stock?
Yahoo - 2025-08-25
Dow Loses About 350 Points After Record-Breaking Run
Yahoo - 2025-08-25
Royalty Pharma (RPRX) Acquires US$885 Million Royalty Interest In Amgen's Imdelltra
Yahoo - 2025-08-25
BeOne Cashes In On Amgen's Cancer Drug Royalties In Multibillion-Dollar Pharma Tie-Up
Yahoo - 2025-08-25
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks
Yahoo - 2025-08-25
REPATHA® NOW INDICATED FOR ADULTS AT INCREASED RISK FOR MAJOR ADVERSE CARDIOVASCULAR EVENTS DUE TO UNCONTROLLED LDL-C
Yahoo - 2025-08-25
Royalty Pharma buys BeOne stake in Amgen lung cancer drug sales
MarketWatch - 2025-08-25
Dow's nearly 250-point fall led by losses for shares of Merck, Sherwin-Williams Co.
Yahoo - 2025-08-25
Royalty Pharma to pay up to $950 million for royalties from Amgen's lung cancer drug
Yahoo - 2025-08-25
Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million
Yahoo - 2025-08-25
BeOne Medicines Announces IMDELLTRA Royalty Purchase Agreement for up to $950 Million
Yahoo - 2025-08-22
Investing in Amgen (NASDAQ:AMGN) three years ago would have delivered you a 35% gain
Yahoo - 2025-08-22
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
Yahoo - 2025-08-21
ReAlta Life Sciences Secures European Orphan Drug Status for Graft-vs-Host Disease Treatment
Yahoo - 2025-08-21
Can J&J Navigate Stelara, Talc Suits, Tariff & Other Headwinds?
Yahoo - 2025-08-21
SINGZYME WINS 2025 AMGEN X NSG GOLDEN TICKET FOR BREAKTHROUGH BIOCONJUGATION PLATFORM
SeekingAlpha - 2025-08-20
S&P 500: Sick Puppies Dominate, But Here's A Trio Of A-List Stocks To Consider
Yahoo - 2025-08-20
Cytokinetics Names Jim Daly to Board of Directors
Yahoo - 2025-08-20
3 Dow Jones Dividend Stocks With Above-Average Yields You Can Buy Now and Hold for at Least a Decade
Yahoo - 2025-08-19
eGenesis Appoints Douglas Williams, Ph.D., and Adam Craig, M.D., Ph.D., to its Board of Directors
SeekingAlpha - 2025-08-19
Bank On Healthcare And An Aging Population With 14% Yield: HQH
SeekingAlpha - 2025-08-18
Columbia Flexible Capital Income Fund Q2 2025 Commentary
MarketWatch - 2025-08-18
Amgen Inc. stock underperforms Monday when compared to competitors
SeekingAlpha - 2025-08-15
Dividend Champion, Contender, And Challenger Highlights: Week Of August 17
Yahoo - 2025-08-15
Amgen (NASDAQ:AMGN) Has A Pretty Healthy Balance Sheet
Yahoo - 2025-08-15
SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease
MarketWatch - 2025-08-15
UnitedHealth, Salesforce share gains contribute to Dow's 213-point climb
SeekingAlpha - 2025-08-14
Back To Basics: Why I Favor Amgen Over Johnson & Johnson
Yahoo - 2025-08-12
5 Insightful Analyst Questions From Amgen’s Q2 Earnings Call
Yahoo - 2025-08-12
AMGN Q2 Deep Dive: Volume Growth, Pipeline Progress, and Guidance Raise Meet Investor Skepticism
SeekingAlpha - 2025-08-12
Vertex Pharmaceuticals: The Stock Hasn't Dropped Enough Yet
Yahoo - 2025-08-11
Amgen Announces Bemarituzumab’s Successful Phase 3 Results in FGFR2b+ Gastric Cancer
SeekingAlpha - 2025-08-11
Vertex Pharmaceuticals Is A Strong Buy After The Recent Pullback (Upgrade)
Yahoo - 2025-08-11
3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates
Yahoo - 2025-08-11
Amgen Insiders Sell US$12m Of Stock, Possibly Signalling Caution
Yahoo - 2025-08-11
Is Trending Stock Amgen Inc. (AMGN) a Buy Now?
SeekingAlpha - 2025-08-08
Is It Too Late To Buy Technology?
Yahoo - 2025-08-08
Amgen's Repatha, Evenity & Blincyto Drive Sales This Earnings Season
SeekingAlpha - 2025-08-07
August Dogs Of The Dow Unleashed 19 'Safer' Dividend Buys
Yahoo - 2025-08-07
Amgen (AMGN) Completes US$60,594 Million Share Buyback After 14 Years
Yahoo - 2025-08-06
NRG Energy, Amgen, Arista Networks: Trending Tickers
Yahoo - 2025-08-06
Amgen Stock Sinks As Market Eyes MariTide's Next Move
Yahoo - 2025-08-06
Why S&P 500 Stock Amgen Stumbled Despite Its Beat-And-Raise Quarter
MarketWatch - 2025-08-06
Amgen Inc. stock underperforms Wednesday when compared to competitors
Yahoo - 2025-08-06
Stock Market Today: Dow Edges Up As Fed Officials Signal Shifts; Nvidia Rival Dives On Earnings (Live Coverage)
Yahoo - 2025-08-06
Amgen's Q2 Earnings & Sales Beat Estimates, 2025 View Raised Slightly
Yahoo - 2025-08-06
Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators
Yahoo - 2025-08-06
OMass Therapeutics Appoints Carol A. Schafer as Non-Executive Director and Chair of the Audit Committee
SeekingAlpha - 2025-08-06
Why I Still Don't Think Amgen Is A Buy
Yahoo - 2025-08-06
Stocks to Watch Wednesday: AMD, Super Micro, Rivian
Yahoo - 2025-08-06
Amgen Inc (AMGN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Robust Pipeline ...
Yahoo - 2025-08-05
Amgen’s (NASDAQ:AMGN) Q2: Beats On Revenue
Yahoo - 2025-08-05
Stocks to Watch Afterhours: AMD, Amgen, Snap
Yahoo - 2025-08-05
Amgen (AMGN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
SeekingAlpha - 2025-08-05
Amgen Inc. 2025 Q2 - Results - Earnings Call Presentation
SeekingAlpha - 2025-08-05
Amgen Inc. (AMGN) Q2 2025 Earnings Call Transcript
Yahoo - 2025-08-05
Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates
Yahoo - 2025-08-05
Amgen Beats Second-Quarter Expectations, So Why Are Shares Diving?
Yahoo - 2025-08-05
Amgen Posts Higher Profit, Revenue On Sales Growth Among Products
Yahoo - 2025-08-05
Amgen inches lower premarket despite second-quarter earnings beat
Yahoo - 2025-08-05
Amgen: Q2 Earnings Snapshot
Yahoo - 2025-08-05
Amgen quarterly results beat Wall Street estimates
Yahoo - 2025-08-05
AMGEN REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS
Yahoo - 2025-08-05
Macro Data, Trade Developments Leave Equities Mixed Intraday
DowJones - 2025-08-05